Psilocybin currently has stronger evidence than ketamine supporting the therapeutic potential of 'emotional breakthroughs' and mystical experiences in the treatment of depression.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (4)

• ketamine concept
• psilocybin concept
• depression concept
• mystical experience concept